Terms: = Gastric cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790 AND Treatment
8 results:
1. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer.
Lee KS; Lee CK; Kwon SS; Kwon WS; Park S; Lee ST; Choi JR; Rha SY; Shin S
Clin Chem Lab Med; 2024 Jan; 62(1):178-186. PubMed ID: 37435889
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
3. FGFR3
Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
[TBL] [Abstract] [Full Text] [Related]
4. Demethylation of the RB1 promoter concomitant with reactivation of tet2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice.
Cao D; Jia Z; Wu Y; Su T; Zhao D; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Dec; 263():118580. PubMed ID: 33058920
[TBL] [Abstract] [Full Text] [Related]
5. Potential role of tet2 in gastric cancer cisplatin resistance.
Zhou K; Guo H; Zhang J; Zhao D; Zhou Y; Zheng Z; Xu Y; Li Y; Wang D
Pathol Res Pract; 2019 Nov; 215(11):152637. PubMed ID: 31570278
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling.
Deng W; Zhang Y; Cai J; Zhang J; Liu X; Yin J; Bai Z; Yao H; Zhang Z
Exp Biol Med (Maywood); 2019 Sep; 244(12):953-959. PubMed ID: 31242038
[TBL] [Abstract] [Full Text] [Related]
7. Loss of function of tet2 cooperates with constitutively active KIT in murine and human models of mastocytosis.
De Vita S; Schneider RK; Garcia M; Wood J; Gavillet M; Ebert BL; Gerbaulet A; Roers A; Levine RL; Mullally A; Williams DA
PLoS One; 2014; 9(5):e96209. PubMed ID: 24788138
[TBL] [Abstract] [Full Text] [Related]
8. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract] [Full Text] [Related]
